Metabolomics implicate eicosanoids in severe functional mitral regurgitation

Metabolomics implicate eicosanoids in severe functional mitral regurgitation

Abstract Aims Secondary, or functional, mitral regurgitation (FMR) was recently recognized as a separate clinical entity, complicating heart failure with reduced ejection fraction (HFrEF) and entailing particularly poor outcome. Currently, there is a lack of targeted therapies for FMR due to the fac...

Full description

Bibliographic Details
Main Authors: Thomas M. Hofbauer, Klaus Distelmaier, Besnik Muqaku, Georg Spinka, Veronika Seidl, Henrike T. Arfsten, Gerhard Hagn, Samuel Meier‐Menches, Philipp E. Bartko, Noemi Pavo, Matthias Hoke, Suriya Prausmueller, Gregor Heitzinger, Dietmar Pils, Irene M. Lang, Christian Hengstenberg, Martin P. Hülsmann, Christopher Gerner, Georg Goliasch
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:ESC Heart Failure
Subjects:
Functional mitral regurgitation
Heart failure
Metabolomics
Eicosanoids
Online Access:https://doi.org/10.1002/ehf2.14160

Internet

https://doi.org/10.1002/ehf2.14160

Similar Items